局部晚期-话题@MedSci

#局部晚期#

176篇内容 | 5039人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650857, encodeId=e347165085e19, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌, objectType=article, longId=729496, objectId=5ebee29496b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ebee29496b6, replyNumber=0, likeNumber=100, createdTime=2022-12-12, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ebee29496b6, moduleTitle=NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ebee29496b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650862, encodeId=62321650862dd, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！, objectType=article, longId=733744, objectId=5b82e33744f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b82e33744f2, replyNumber=0, likeNumber=136, createdTime=2023-03-21, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b82e33744f2, moduleTitle=JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b82e33744f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650831, encodeId=d094165083112, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=免费回看：围手术期及局部晚期NSCLC免疫治疗进展, objectType=article, longId=221669, objectId=1f902216690f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f902216690f, replyNumber=0, likeNumber=64, createdTime=2022-07-03, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f902216690f, moduleTitle=免费回看：围手术期及局部晚期NSCLC免疫治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f902216690f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650842, encodeId=a74316508426b, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, objectType=article, longId=299451, objectId=fc31299451e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc31299451e9, replyNumber=0, likeNumber=96, createdTime=2022-09-09, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc31299451e9, moduleTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc31299451e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650850, encodeId=34271650850e9, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, objectType=article, longId=723550, objectId=0c6ae23550d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c6ae23550d2, replyNumber=0, likeNumber=84, createdTime=2023-03-13, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c6ae23550d2, moduleTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c6ae23550d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650837, encodeId=d807165083ecb, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, objectType=article, longId=293023, objectId=5fe32930236d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe32930236d, replyNumber=0, likeNumber=61, createdTime=2022-10-19, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe32930236d, moduleTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe32930236d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650816, encodeId=5e1d1650816b0, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素, objectType=article, longId=217443, objectId=bacd21e4438e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bacd21e4438e, replyNumber=0, likeNumber=98, createdTime=2022-06-28, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bacd21e4438e, moduleTitle=Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bacd21e4438e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650819, encodeId=8fac165081970, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, objectType=article, longId=218067, objectId=2f5021806e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f5021806e4d, replyNumber=0, likeNumber=105, createdTime=2021-11-04, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f5021806e4d, moduleTitle=Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f5021806e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650858, encodeId=5fcd1650858f5, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, objectType=article, longId=729559, objectId=1586e2955944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1586e2955944, replyNumber=0, likeNumber=107, createdTime=2022-09-15, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1586e2955944, moduleTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1586e2955944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650825, encodeId=25f21650825f6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, objectType=article, longId=219626, objectId=89d3219626c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d3219626c9, replyNumber=0, likeNumber=104, createdTime=2022-02-28, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d3219626c9, moduleTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d3219626c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650859, encodeId=62b41650859db, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤, objectType=article, longId=730250, objectId=b725e302503d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b725e302503d, replyNumber=0, likeNumber=82, createdTime=2022-10-31, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b725e302503d, moduleTitle=JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b725e302503d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650839, encodeId=7c75165083938, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素, objectType=article, longId=294336, objectId=919e2943363f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=919e2943363f, replyNumber=0, likeNumber=75, createdTime=2023-01-05, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=919e2943363f, moduleTitle=Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=919e2943363f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650817, encodeId=417a165081eb1, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, objectType=article, longId=217450, objectId=f9a121e450ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9a121e450ea, replyNumber=0, likeNumber=110, createdTime=2022-04-11, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9a121e450ea, moduleTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9a121e450ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650848, encodeId=c737165084868, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, objectType=article, longId=301810, objectId=b131301810c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b131301810c5, replyNumber=0, likeNumber=108, createdTime=2022-09-16, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b131301810c5, moduleTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b131301810c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650818, encodeId=b0e716508181e, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, objectType=article, longId=217734, objectId=763321e734eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763321e734eb, replyNumber=0, likeNumber=102, createdTime=2022-05-29, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763321e734eb, moduleTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763321e734eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650841, encodeId=7519165084177, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！, objectType=article, longId=295321, objectId=eb062953218f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb062953218f, replyNumber=0, likeNumber=0, createdTime=2022-11-23, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb062953218f, moduleTitle=Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb062953218f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650820, encodeId=34c316508207d, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画, objectType=article, longId=218426, objectId=70c521842614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70c521842614, replyNumber=0, likeNumber=98, createdTime=2022-04-12, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70c521842614, moduleTitle=今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70c521842614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650829, encodeId=056c165082954, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Front Oncol：分析术前放疗对比术后放疗对局部晚期乳腺癌(LABC)患者的总生存影响, objectType=article, longId=221258, objectId=c41422125898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c41422125898, replyNumber=0, likeNumber=80, createdTime=2022-01-28, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c41422125898, moduleTitle=Front Oncol：分析术前放疗对比术后放疗对局部晚期乳腺癌(LABC)患者的总生存影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c41422125898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650838, encodeId=23fa165083888, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, objectType=article, longId=292998, objectId=6f1329299826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1329299826, replyNumber=0, likeNumber=85, createdTime=2022-02-13, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1329299826, moduleTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1329299826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650832, encodeId=55411650832bf, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=DCR: 慢性肾脏病对接受新辅助放化疗治疗的局部晚期直肠癌患者的预后影响, objectType=article, longId=265010, objectId=4dc6265010cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dc6265010cc, replyNumber=0, likeNumber=97, createdTime=2022-05-03, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dc6265010cc, moduleTitle=DCR: 慢性肾脏病对接受新辅助放化疗治疗的局部晚期直肠癌患者的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc6265010cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部晚期

2020-05-29

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

NEJM Evid：durvalumab联合标准化疗治疗局部晚期或转移性胆道癌

2022-12-12

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！

2023-03-21

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

免费回看：围手术期及局部晚期NSCLC免疫治疗进展

2022-07-03

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效

2022-09-09

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后

2023-03-13

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果

2022-10-19

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Gynecol Oncol：鳞状细胞癌抗原（SCC-Ag）是局部晚期宫颈癌患者的生存预后因素

2022-06-28

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Front Oncol： FOLT方案围手术期治疗中国局部晚期胃癌的可行性和安全性

2021-11-04

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤

2022-09-15

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究

2022-02-28

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA Oncol：DDGP方案 vs SMILE方案治疗新诊断的局部晚期结外自然杀伤/T细胞淋巴瘤

2022-10-31

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Cancers：多中心研究探索局部晚期 Merkel细胞癌的治疗、预后以及相关因素

2023-01-05

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据

2022-04-11

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性

2022-09-16

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性

2022-05-29

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！

2022-11-23

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

今晚7点直播 | 不可手术局部晚期非小细胞肺癌的靶区勾画

2022-04-12

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Front Oncol：分析术前放疗对比术后放疗对局部晚期乳腺癌(LABC)患者的总生存影响

2022-01-28

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？

2022-02-13

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

DCR: 慢性肾脏病对接受新辅助放化疗治疗的局部晚期直肠癌患者的预后影响

2022-05-03

科室
- - 订阅+
  - 更多科室
工具
服务